Gene Expression Analysis Market Size, Share and Trends 2026 to 2035
Gene Expression Analysis Market (By Product and Service:: Reagents and Consumables, Instruments, Services; By Application: Drug Discovery and Development, Clinical Diagnostics, Other Applications; By End User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Other End Users) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035
Get a Sample
Table Of Content
What is Gene Expression Analysis Market Size in 2026?
The global gene expression analysis market size was calculated at USD 5.26 billion in 2025 and is predicted to increase from USD 5.71 billion in 2026 to approximately USD 11.92 billion by 2035, expanding at a CAGR of 8.52% from 2026 to 2035. The gene expression profiling and quantitation revolve around RNA expression, promoter analysis, protein expression, and posttranslational modification analysis.
Key Takeaways
- North America dominated the gene expression analysis market in 2025.
- Asia Pacific is expected to grow at the fastest CAGR in the market during the forecast period.
- By product and service, the reagents and consumables segment dominated the market in 2025.
- By product and service, the instruments segment in the market is expected to grow at the fastest CAGR in the market during the forecast period.
- By application, the drug discovery and development segment dominated the market in 2025.
- By application, the clinical diagnostics segment is expected to grow at the fastest rate in the market in 2025.
- By end user, the pharmaceutical and biotechnology companies segment dominated the market in 2025.
- By end user, the academic and research institutes segment is expected to grow at the fastest CAGR in the market during the forecast period.
Gene Expression Analysis: Driving Gene Transcription
The gene expression analysis market is experiencing massive growth due to different efficient techniques, such as northern blotting, DNA microarrays, and real-time PCR for RNA expression. On the other hand, techniques used for protein expression include western blotting, 2-D gel electrophoresis, and immunoassays. Researchers employ numerous molecular biology techniques and experimental methods to study gene expression. Gene expression analysis studies are categorized into four areas: promoter analysis, RNA expression, protein expression, and post-translational modification.
How is AI Revolutionizing the Gene Expression Analysis Market?
Artificial Intelligence links genomic data with protein functions and boosts the discovery of functional molecules from DNA sequences, which help in drug discovery and personalized medicine. AI, machine learning , and deep learning have enabled the precise interpretation of complex genomic and proteomic data. AI improves transparency and integration of complex biological data, and ensures ethical training and fairness across the expanding gene expression analysis market. It is revolutionizing healthcare with responsible and personalized AI-driven solutions. AI helps in the precise analysis of biological data and the identification of disease-causing mutations.
Gene Expression Analysis Market Trends
- Single-Cell RNA Sequencing: This technique remains the largest sequencing type due to its ability to introduce cellular heterogeneity in immunology, cancer, and neuroscience. The leading companies are making partnerships to analyze complex datasets.
- Spatial Transcriptomics: It is the rising trend in the gene expression analysis market due to expanding research across precision medicine, neuroscience, and oncology. The heavy investments in R&D and early adoption of clinical research are driving the expansion of spatial transcriptomics.
- High-Resolution Technologies: These include spatial transcriptomics, single-cell RNA sequencing, and long-read sequencing. The new high-throughput systems offer faster and lower-cost single-cell analysis. The emerging trends and digital integration include AI-powered bioinformatics, CRISPR-based functional genomics, and liquid biopsy platforms.
- Long-Read Sequencing: It allows for the sequencing of entire RNA isoforms without fragmenting them. It also enables the discovery of gene fusions and novel splice variants that are important for cancer research.
- Identification of Rare Cell Populations: The detection of rare cell populations is important to identify tumor heterogeneity and drive research on precision oncology . Researchers are combining gene expression with protein markers to verify rare cell states.
Market Scope
| Report Coverage | Details |
| Market Size in 2025 | USD 5.26 Billion |
| Market Size in 2026 | USD 5.71 Billion |
| Market Size by 2035 | USD 11.92 Billion |
| Market Growth Rate from 2026 to 2035 | CAGR of 8.52% |
| Dominating Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | Product and Service, Application, End-User, and region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Segmental Insights
Product and Service Insights
How did the Reagents and Consumables Segment Dominate the Gene Expression Analysis Market in 2025?
The reagents and consumables segment dominated the market in 2025, owing to the wide use of reagents in laboratory workflows, research projects, research institutes, and academic projects. Researchers, students, and professionals increasingly use reagents and consumables to perform gene expression analysis, molecular biology experiments, and other scientific research. They are ideal for their defined storage conditions, chemical properties, and promising results.
The instruments segment is expected to grow at the fastest CAGR in the gene expression analysis market during the forecast period due to the huge dependency of researchers on numerous instruments to conduct desirable research. The laboratories are backed by investments, funds, and policies to incorporate biological instruments like centrifuges, laminar air flow, autoclave, SDS PAGE, nanodrop, electrophoresis apparatus, etc. These instruments undergo timely calibration, cleaning, and monitoring to ensure precise and accurate experimental results.
Application Insights
What made Drug Discovery and Development the Dominant Segment in the Gene Expression Analysis Market in 2025?
The drug discovery and development segment dominated the market in 2025, owing to the emerging challenges associated with pandemic and epidemic cases, and the urgent need for vaccine design and development. Researchers and manufacturers are using advanced tools and techniques to design, produce, launch, and commercialize potential vaccines and pharmaceutical drugs. The new drugs with safety, efficacy, and effectiveness undergo stringent regulatory compliance and mandates.
The clinical diagnostics segment is estimated to grow at the fastest rate in the gene expression analysis market during the predicted timeframe due to the rapid shift towards promising diagnostics and therapeutics. The integration of advanced tools and technologies like AI, ML, precision medicine, combination therapies, genetic profiling, and targeted therapies is advancing clinical diagnostics and therapeutics. Robust research on the detection, diagnosis, prevention, and treatment of various types of diseases, such as cancer, obesity, diabetes, muscular disorders, and many other chronic conditions, drives the need for promising clinical diagnostics.
End User Insights
How did the Pharmaceutical and Biotechnology Companies Segment Dominate the Gene Expression Analysis Market in 2025?
The pharmaceutical and biotechnology companies segment dominated the market in 2025, owing to the massive expansion of biopharmaceutical companies across the world. Research excellence, strong leadership, network strategies, growing collaborations and acquisitions, and consumer trust are the major driving forces for the global pharmaceutical and biotechnology companies. They build trust with local and international market players to drive novel research and innovation.
The academic and research institutes segment is anticipated to grow at a notable rate in the gene expression analysis market during the upcoming period due to the expertise of scientific and medical professionals, well-equipped facilities, and global reach. They perform critical and careful research on the ongoing trends and emerging global health crises. They support with AI and data integration, real-time insights, oncology research, and therapeutic monitoring.
Regional Insights
How does North America dominate the Gene Expression Analysis Market in 2025?
North America dominated the market in 2025, owing to its robust research infrastructure, personalized medicine trends, and significant government funding for R&D in genomics, proteomics, and personalized medicine. The new technologies are integrating clinical workflows, and regions are expanding due to robust research infrastructure. The leading companies, like Bio-Rad Laboratories, Illumina Inc., Thermo Fisher Scientific Inc., and GeneCentric Therapeutics, are investing in cell and gene therapies. Moreover, the other leading companies, like Thermo Fisher Scientific Inc. and IBM, have collaborated to develop AI-powered genomic tools.
U.S. Gene Expression Analysis Market Analysis
The U.S. industry experiences continuous innovations in next-generation sequencing, precision medicine, drug discovery, single-cell analysis, and other technologies across the market. In September 2025, the Advanced Research Projects Agency for Health (ARPA-H) launched a revolutionary program to develop affordable precision genetic medicines for all Americans.
What is the Potential of the Gene Expression Analysis Market in the Asia Pacific?
Asia Pacific is expected to grow at the fastest CAGR in the market during the forecast period due to national genomic initiatives, strong R&D in pharmaceutical and biotechnology, and cost-effective manufacturing. The major driving forces for the Asian Pacific market are the national genomics and database initiatives, agricultural biotechnology, gene editing, funding, and startup initiatives. The government accelerates early-stage innovation, and global leaders like Pfizer and AstraZeneca have built multi-billion-dollar R&D facilities to use regional expertise.
India Market Trends
The national biopharma mission, BioE3 policy, the Genome India project, and other strategic initiatives are driving the gene expression analysis market in India. In February 2026, Jitendra Singh, the Union Minister, proclaimed that India is advancing in genomics and gene therapy .
How is the Noticeable Growth of Europe in the Market?
Europe is expected to grow at a notable rate in the market, owing to streamlined R&D workflows, global pharmaceutical players, and heavy investments in drug discovery and gene therapy. The EU's flagship '1+ Million Genomes' (1+MG) initiative is launched to enable secure access to clinical data and genomics across Europe to support revolutionary research and policies. The European Union strongly focuses on patient-friendly and citizen-focused genomic research and collaboration.
Germany Market Analysis
The rising demand for targeted molecular therapeutics, the expansion of precision medicine, and the cost-effective and high-throughput analysis of millions of DNA sequences drive the gene expression analysis market in Germany. The German federal government introduced a new national strategy on cell and gene therapies.
Gene Expression Analysis Market Value Chain Analysis
Top Companies in the Gene Expression Analysis Market and Their Offerings
- Illumina: Illumina Single Cell 3' RNA Prep, Illumina Protein Prep, MiSeq i100 Series, Perturb-seq solution, NovaSeq X series updates, Illumina connected multiomics, promoter AI.
- Thermo Fisher Scientific: SwiftArrayStudio microarray analyzer, Axiom PharmacoPro & PangenomePro arrays, Gibco™ Expi293 PRO expression system, Invitrogen™ TaqMan™ Cells-to-CT™ Express Kit, MagMAX™ Sequential DNA/RNA Kit.
- Agilent Technologies: Microarray platforms, next-generation sequencing solutions, quantitative PCR, etc.
- Bio-Rad Laboratories: ddSEQ Single-Cell 3′ RNA-Seq kit, QX Continuum ddPCR system, QX700 Series ddPCR systems, ddPLEX ESR1 mutation detection kit, Vericheck ddPCR kits.
- QIAGEN: QIAcuity digital PCR system, QIAsymphony Connect, QIAsprint Connect, QIAcuity dPCR kits, etc.
Other Companies in the Gene Expression Analysis Market
- 10x Genomics
- Pacific Biosciences
- Oxford Nanopore Technologies
- NanoString Technologies
- Roche Holding AG
- BGI Genomics
- PerkinElmer
Recent Developments
- In January 2026, Illumina Inc. announced the launch of a powerful cloud-based research software platform for scalable, intuitive, and connected multiomic analysis. This platform was introduced to analyze and visualize multimodal and multiomic biological data at scale.(Source: https://www.illumina.com/com )
- In January 2026, Thermo Fisher Scientific Inc. launched the HepatoExpress kit for liver cell gene expression analysis without requiring RNA purification. Researchers can complete sample-to-result workflows within 75 minutes by using these kits compared to traditional gene expression analysis using RNA extraction columns or magnetic beads, which takes two to three hours.
Segments Covered in the Report
By Product and Service
- Reagents and Consumables
- Assay and Kits
- Enzymes
- DNA Chips
- Other Reagents and Consumables
- Instruments
- PCR
- NGS
- DNA Microarrays
- Other Instruments
- Services
- Gene Expression Analysis Services
- RNA Sequencing Services
- Other Services
- Bioinformatics Solutions
- Gene Expression Analysis Services
By Application
- Drug Discovery and Development
- Clinical Diagnostics
- Other Applications
By End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Other End User
By Region
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East & Africa
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
Frequently Asked Questions
Ask For Sample
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
sales@precedenceresearch.com
+1 804-441-9344
Schedule a Meeting